Dow Up 0.00% Nasdaq Up 0.09%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM
2.96 Down 0.05(1.66%) Nov 28, 12:54PM EST
Prev Close:3.01
Open:3.01
Bid:2.75 x 200
Ask:3.03 x 100
1y Target Est:9.00
Beta:0.39
Next Earnings Date:N/A
Day's Range:2.93 - 3.01
52wk Range:2.68 - 5.25
Volume:18,038
Avg Vol (3m):94,492
Market Cap:68.01M
P/E (ttm):N/A
EPS (ttm):-0.88
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYCC

Comparison

Symbol% ChgMkt Cap
CYCCDown 1.66%68.01M
AZNUp 0.35%93.68B
JNJUp 0.97%303.00B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):38.72
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Dec-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback